A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer

Por Zelek, L, Yovine, A, Brain, E, Turpin, F, Taamma, A, Riofrio, M, Spielmann, M, Jimeno, J, Misset, J L
Publicado em 2006

Therapeutic Evaluation of Tumor Necrosis Factor-alpha Antagonist Etanercept against Traumatic Brain...

Por Hasturk, Askin Esen, Gokce, Emre Cemal, Yilmaz, Erdal Resit, Horasanli, Bahriye, Evirgen, Oya, Hayirli, Nazli, Gokturk, Hilal, Erguder, Imge, Can, Belgin
Publicado no Asian J Neurosurg (2018)

Phase III trial (EORTC 10994/BIG 1-00) assessing the value of p53 using a functional assay to predict sensitivity to a taxane versus non taxane primary chemotherapy in breast cance...

Por Bonnefoi, Hervé, Piccart, Martine, Bogaerts, Jan, Mauriac, Louis, Fumoleau, Pierre, Brain, Etienne, Petit, Thierry, Rouanet, Philippe, Jassem, Jacek, Blot, Emmanuel, Zaman, Khalil, Cufer, Tanja, Lortholary, Alain, Lidbrink, Elisabet, André, Sylvie, Litière, Saskia, Lago, Lissandra Dal, Becette, Véronique, Cameron, David A., Bergh, Jonas, Iggo, Richard
Publicado em 2011

How we treat patients with brain tumour during the COVID-19 pandemic

Por Weller, Michael, Preusser, Matthias
Publicado no ESMO Open (2019)

Imaging biomarkers of brain tumour margin and tumour invasion

Por Price, S J, Gillard, J H
Publicado em 2011

Focal chemotherapy of brain tumours using semipermeable membranes.

Por Wilkinson, H A, Kornblith, P, Weems, S
Publicado em 1977

Endocrine disorders following treatment of childhood brain tumours.

Por Livesey, E. A., Hindmarsh, P. C., Brook, C. G., Whitton, A. C., Bloom, H. J., Tobias, J. S., Godlee, J. N., Britton, J.
Publicado em 1990

Brain tumour post-treatment imaging and treatment-related complications

Por Kessler, Alexander T., Bhatt, Alok A.
Publicado no Insights Imaging (2018)

P09 CAN RAPIDARC(®) IMPROVE THE OUTCOME OF GLIOMAS TREATED WITH RADIOTHERAPY?

Por Crossley, Dr Richard, Henshaw, Michael, Hill, Melissa, Foran, Dr Bernadette
Publicado em 2014

SCIDOT-08. CHILDREN’S BRAIN TUMOUR DRUG DELIVERY CONSORTIUM (CBTDDC)

Por Rahman, Ruman, Campbell, Emma, Brem, Henry, Pearl, Monica, Green, Jordan, Janowski, Miroslaw, Walczak, Piotr, Tyler, Betty, Warren, Katherine, Singleton, Will, Mullen, Alexander, Boyd, Marie, Veal, Gareth, Hargrave, Darren, van Vuurden, Dannis, Powell, Steven, Battaglia, Giuseppe, Vivanco, Igor, Al-Jamal, Khuloud, Walker, David
Publicado no Neuro Oncol (2019)

Using surgical and oncology workload to plan brain tumour trial recruitment in England

Por Le Calvez, Kerlann, Treasure, Peter, Williams, Matt
Publicado no Neuro Oncol (2019)

SMART syndrome: a late reversible complication after radiation therapy for brain tumours

Por Kerklaan, Joost P., Lycklama á Nijeholt, Geert J., Wiggenraad, Ruud G. J., Berghuis, Bianca, Postma, Tjeerd J., Taphoorn, Martin J. B.
Publicado em 2011

PP31. A SYSTEMATIC REVIEW OF THE EFFECT OF CASELOAD ON OUTCOMES IN BRAIN TUMOUR SURGERY

Por Wan, Mr Yizhou, Hassan, Dr Syed
Publicado no Neuro Oncol (2017)

P12 A PHASE I TRIAL OF INTRAVENOUS ONCOLYTIC REOLYSIN(®) IN PATIENTS WITH BRAIN TUMOURS

Por Jebar, A., West, E., Scott, K., Thomson, S., Corns, R., Mathew, R., SivaKumar, G., Coffey, M., Nuovo, G., Rose, A., Ralph, C., Twelves, C., Anthoney, A., Griffin, S., Short, S., Melcher, A.
Publicado em 2014

P07.18 Characterization and identification of glioblastoma progression on preoperative multimodal MRI

Por Yan, J., van der Hoorn, A., Boonzaier, N. R., Matys, T., Price, S. J.
Publicado no Neuro Oncol (2016)

HOW SHOULD WE SUPPORT PATIENTS WITH PRIMARY BRAIN TUMOURS WHO ELECT TO TAKE CANNABINOIDS?

Por La, Jessica, Hurwitz, Victoria, Mullens, Laura, Brazil, Lucy, Gullan, Richard, Bhangoo, Ranj, Vergani, Francesco, Beaney, Ronald, Ashkan, Keyoumars, Rooprai, Bali, Swampillai, Angela
Publicado no Neuro Oncol (2018)

P07.12 Multimodal imaging of the invasive microenvironment predicts survival in glioblastomas

Por Price, S. J., Boonzaier, N. R., Yan, J., McLean, M. A.
Publicado no Neuro Oncol (2016)

P10.03 The prognostic role of primary treatment in pediatric High-Grade Gliomas: the experience at Meyer Children’s Hospital

Por Lucchesi, M., Scoccianti, S., Guidi, M., Facchini, L., Farina, S., Fonte, C., Favre, C., Genitori, L., Sardi, I.
Publicado no Neuro Oncol (2016)

Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture

Por Marques-Torrejon, Maria Angeles, Gangoso, Ester, Pollard, Steven M.
Publicado no Dis Model Mech (2018)

Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours

Por Nagtegaal, S.H.J., Hulsbergen, A.F.C., van Dorst, E.B.L., Kavouridis, V.K., Jessurun, C.A.C., Broekman, M.L.D., Smith, T.R., Verhoeff, J.J.C.
Publicado no Clin Transl Radiat Oncol (2020)